<DOC>
	<DOCNO>NCT01936285</DOCNO>
	<brief_summary>- There evidence inflammatory process may play detrimental role acute phase myocardial infarction - The hypothesis study colchicine , anti-inflammatory action , may lead reduction infarct size , administer acute phase myocardial infarction</brief_summary>
	<brief_title>Colchicine ST-elevation Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<criteria>The study enroll patient 18 year old old present hospital within twelve ( 12 ) hour onset chest pain ST segment elevation &gt; 1 mm two contiguous limb lead ST segment elevation &gt; 2 mm two consecutive precordial lead new onset leave bundle branch block ( LBBB ) twelve lead electrocardiogram decision make take cath lab perform angioplasty coronary vessel . Excluded patient : &gt; 80 year old active inflammatory disease , infectious disease know malignancy treatment corticosteroid , antiinflammatory agent disease modify agent know hypersensitivityallergy colchicine chronic treatment colchicine severe renal failure ( eGFR &lt; 30 ml/min/1.73 m2 ) hepatic failure ( Child Pugh class B C ) present cardiac arrest present ventricular fibrillation present cardiogenic shock stent thrombosis angina within 48 hour infarction previous myocardial infarction occlusion leave main leave circumflex coronary artery evidence coronary collateral region risk initial coronary angiography ( time admission ) metallic implant ( ferromagnetic material )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>